1 |
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Scidman, J. G., Smith, R. A. and Struhl, K. 2002. Short Protocols in Molecular Biology. (John Wiley & Sons, New York, NY, USA).
|
2 |
Babji, S. and Kang, G. 2012. Rotavirus vaccination in developing countries. Curr. Opin. Virol. 2, 443-448.
DOI
|
3 |
Brown, W. C. and Campbell, J. L. A., 1993. New cloning vector and expression strategy for genes encoding proteins toxic to Escherichia coli. Gene 127, 99-103.
DOI
|
4 |
Chung, C. T., Niemela, S. L. and Miller, R. H. 1989. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci. USA. 86, 2172-2175.
DOI
|
5 |
Coligan, J. E., Dunn, B. M., Speicher, D. W. and Wingfield, P. T. 2003. Short Protocols in Protein Science. (John Wiley & Sons, New York, NY, USA).
|
6 |
Doro, R., Laszlo, B., Martella, V., Leshem, E., Gentsch, J., Parashar, U. and Banyai, K. 2014. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure? Infect. Genet. Evol. 28, 446-461.
DOI
|
7 |
Kim, H. S., Lee, B., Han, S. Y. and Jung, Y. T. 2017. Expression of bovine rotavirus VP8 and preparation of IgY antibodies against recombinant VP8. Acta Virol. 61, 143-149.
DOI
|
8 |
Favacho, A. R., Kurtenbach, E., Sardi, S. I. and Gouvea, V. S. 2006. Cloning, expression, and purification of recombinant bovine rotavirus hemagglutinin, VP8*, in Escherichia coli. Protein Expr. Purif. 46, 196-203
DOI
|
9 |
Hoshino, Y. and Kapikian, A. Z. 2000. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development. J. Health Popul. Nutr. 18, 5-14.
|
10 |
Kang, D. K., Kim, P. H., Ko, E. J., Seo, J. Y., Seong, S. Y., Kim, Y. H., Kwon, I. C., Jeong, S. Y. and Yang, J. M. 1999. Peroral immunization of microencapsulated human VP8* in combination with cholera toxin induces strong systemic and intestinal antibody responses. Mol. Cells 9, 609-616
|
11 |
Kovacs-Nolan, J., Sasaki, E., Yoo, D. and Mine, Y. 2001. Cloning and expression of human rotavirus spike protein, VP8*, in Escherichia coli. Biochem. Biophys. Res. Commun. 282, 1183-1188.
DOI
|
12 |
Leenaars, P. P., Hendriksen, C. F., de Leeuw, W. A., Carat, F., Delahaut, P., Fischer, R., Halder, M., Hanly, W. C., Hartinger, J., Hau, J., Lindblad, E. B., Nicklas, W., Outschoorn, I. M. and Stewart-Tull, D. E. 1999. The Production of polyclonal antibodies in laboratory animals. The report and recommendations of ECVAM workshop 35. Altern. Lab. Anim. 27, 79-102.
|
13 |
Lepault, J. 2001. Structural polymorphism of the major capsid protein of rotavirus. EMBO J. 20, 1498-1507.
DOI
|
14 |
Parashar, U. D., Hummelman, E. G., Bresee, J. S., Miller, M. A. and Glass, R. I. 2003. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9, 565-572.
DOI
|
15 |
Xue, M., Yu L., Jia, L., Li, Y., Zeng, Y., Li, T., Ge, S. and Xia, N. 2016. Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model. Hum. Vaccin. Immunother. 12, 2959-2968.
DOI
|
16 |
Pera, F. F., Mutepfa, D. L., Khan, A. M., Els, J. H., Mbewana, S., van Dijk, A. A., Rybicki, E. P. and Hitzeroth, II. 2015. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana. Virol. J. 12, 205-215.
DOI
|
17 |
Ruiz, M. C., Leon, T., Diaz, Y. and Michelangeli, F. 2009 Molecular biology of rotavirus entry and replication. Sci. World J. 9, 1476-1497.
DOI
|
18 |
Wen, X., Cao, D., Jones, R. W., Li, J., Szu, S. and Hoshino, Y. 2012. Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates. Vaccine 30, 6121-6126.
DOI
|